vs
Kenvue（KVUE）与RENAISSANCERE HOLDINGS LTD（RNR）财务数据对比。点击上方公司名可切换其他公司
Kenvue的季度营收约是RENAISSANCERE HOLDINGS LTD的1.7倍（$3.8B vs $2.2B），RENAISSANCERE HOLDINGS LTD净利率更高（23.5% vs 8.7%，领先14.8%），Kenvue同比增速更快（3.2% vs -36.8%），过去两年Kenvue的营收复合增速更高（-1.5% vs -11.9%）
Kenvue是美国消费者健康企业，前身为强生集团消费者健康业务部门，旗下拥有邦迪、李施德林、露得清、泰诺、强生婴儿、仙特明等诸多知名消费健康品牌，总部现位于美国新泽西州萨米特。
RenaissanceRe Holdings Ltd是总部位于百慕大的保险及相关商业服务提供商，核心业务覆盖再保险、常规保险两大板块，同时运营风险相关创新投资业务，为全球客户提供专业的风险对冲与保险解决方案。
KVUE vs RNR — 直观对比
营收规模更大
KVUE
是对方的1.7倍
$2.2B
营收增速更快
KVUE
高出40.0%
-36.8%
净利率更高
RNR
高出14.8%
8.7%
两年增速更快
KVUE
近两年复合增速
-11.9%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $3.8B | $2.2B |
| 净利润 | $330.0M | $515.8M |
| 毛利率 | 56.5% | — |
| 营业利润率 | 14.2% | — |
| 净利率 | 8.7% | 23.5% |
| 营收同比 | 3.2% | -36.8% |
| 净利润同比 | 12.6% | 72.6% |
| 每股收益（稀释后） | $0.16 | $6.57 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KVUERNR
| Q1 26 | — | $2.2B | ||
| Q4 25 | $3.8B | $3.0B | ||
| Q3 25 | $3.8B | $3.2B | ||
| Q2 25 | $3.8B | $3.2B | ||
| Q1 25 | $3.7B | $3.5B | ||
| Q4 24 | $3.7B | $2.3B | ||
| Q3 24 | $3.9B | $4.0B | ||
| Q2 24 | $4.0B | $2.8B |
净利润KVUERNR
| Q1 26 | — | $515.8M | ||
| Q4 25 | $330.0M | $760.5M | ||
| Q3 25 | $398.0M | $916.5M | ||
| Q2 25 | $420.0M | $835.4M | ||
| Q1 25 | $322.0M | $170.0M | ||
| Q4 24 | $293.0M | $-189.7M | ||
| Q3 24 | $383.0M | $1.2B | ||
| Q2 24 | $58.0M | $503.9M |
毛利率KVUERNR
| Q1 26 | — | — | ||
| Q4 25 | 56.5% | — | ||
| Q3 25 | 59.1% | — | ||
| Q2 25 | 58.9% | — | ||
| Q1 25 | 58.0% | — | ||
| Q4 24 | 56.5% | — | ||
| Q3 24 | 58.5% | — | ||
| Q2 24 | 59.1% | — |
营业利润率KVUERNR
| Q1 26 | — | — | ||
| Q4 25 | 14.2% | 42.5% | ||
| Q3 25 | 16.7% | 46.3% | ||
| Q2 25 | 18.0% | 41.8% | ||
| Q1 25 | 14.9% | -2.0% | ||
| Q4 24 | 13.2% | -3.6% | ||
| Q3 24 | 16.8% | 43.7% | ||
| Q2 24 | 3.9% | 25.0% |
净利率KVUERNR
| Q1 26 | — | 23.5% | ||
| Q4 25 | 8.7% | 25.6% | ||
| Q3 25 | 10.6% | 28.7% | ||
| Q2 25 | 10.9% | 26.1% | ||
| Q1 25 | 8.6% | 4.9% | ||
| Q4 24 | 8.0% | -8.3% | ||
| Q3 24 | 9.8% | 29.8% | ||
| Q2 24 | 1.5% | 17.8% |
每股收益（稀释后）KVUERNR
| Q1 26 | — | $6.57 | ||
| Q4 25 | $0.16 | $16.16 | ||
| Q3 25 | $0.21 | $19.40 | ||
| Q2 25 | $0.22 | $17.20 | ||
| Q1 25 | $0.17 | $3.27 | ||
| Q4 24 | $0.16 | $-3.76 | ||
| Q3 24 | $0.20 | $22.62 | ||
| Q2 24 | $0.03 | $9.41 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.1B | $1.6B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $10.8B | $4.3B |
| 总资产 | $27.1B | $53.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资KVUERNR
| Q1 26 | — | $1.6B | ||
| Q4 25 | $1.1B | $1.7B | ||
| Q3 25 | $1.1B | $1.7B | ||
| Q2 25 | $1.1B | $1.4B | ||
| Q1 25 | $1.1B | $1.6B | ||
| Q4 24 | $1.1B | $1.7B | ||
| Q3 24 | $1.1B | $1.6B | ||
| Q2 24 | $1.0B | $1.6B |
总债务KVUERNR
| Q1 26 | — | — | ||
| Q4 25 | — | $2.3B | ||
| Q3 25 | — | $2.2B | ||
| Q2 25 | — | $2.3B | ||
| Q1 25 | — | $2.8B | ||
| Q4 24 | — | $1.9B | ||
| Q3 24 | — | $1.9B | ||
| Q2 24 | — | $2.0B |
股东权益KVUERNR
| Q1 26 | — | $4.3B | ||
| Q4 25 | $10.8B | $11.6B | ||
| Q3 25 | $10.6B | $11.5B | ||
| Q2 25 | $10.7B | $10.8B | ||
| Q1 25 | $10.1B | $10.3B | ||
| Q4 24 | $9.7B | $10.6B | ||
| Q3 24 | $10.6B | $11.2B | ||
| Q2 24 | $10.2B | $10.2B |
总资产KVUERNR
| Q1 26 | — | $53.7B | ||
| Q4 25 | $27.1B | $53.8B | ||
| Q3 25 | $27.2B | $54.5B | ||
| Q2 25 | $27.1B | $54.7B | ||
| Q1 25 | $26.3B | $53.6B | ||
| Q4 24 | $25.6B | $50.7B | ||
| Q3 24 | $26.9B | $52.8B | ||
| Q2 24 | $26.4B | $51.6B |
负债/权益比KVUERNR
| Q1 26 | — | — | ||
| Q4 25 | — | 0.20× | ||
| Q3 25 | — | 0.19× | ||
| Q2 25 | — | 0.21× | ||
| Q1 25 | — | 0.27× | ||
| Q4 24 | — | 0.18× | ||
| Q3 24 | — | 0.17× | ||
| Q2 24 | — | 0.19× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $854.0M | — |
| 自由现金流经营现金流 - 资本支出 | $744.0M | — |
| 自由现金流率自由现金流/营收 | 19.7% | — |
| 资本支出强度资本支出/营收 | 2.9% | — |
| 现金转化率经营现金流/净利润 | 2.59× | — |
| 过去12个月自由现金流最近4个季度 | $1.7B | — |
8季度趋势，按日历期对齐
经营现金流KVUERNR
| Q1 26 | — | — | ||
| Q4 25 | $854.0M | $483.0M | ||
| Q3 25 | $294.0M | $1.6B | ||
| Q2 25 | $621.0M | $1.5B | ||
| Q1 25 | $428.0M | $157.8M | ||
| Q4 24 | $793.0M | $778.9M | ||
| Q3 24 | $249.0M | $1.5B | ||
| Q2 24 | $440.0M | $1.2B |
自由现金流KVUERNR
| Q1 26 | — | — | ||
| Q4 25 | $744.0M | — | ||
| Q3 25 | $196.0M | — | ||
| Q2 25 | $533.0M | — | ||
| Q1 25 | $249.0M | — | ||
| Q4 24 | $661.0M | — | ||
| Q3 24 | $190.0M | — | ||
| Q2 24 | $350.0M | — |
自由现金流率KVUERNR
| Q1 26 | — | — | ||
| Q4 25 | 19.7% | — | ||
| Q3 25 | 5.2% | — | ||
| Q2 25 | 13.9% | — | ||
| Q1 25 | 6.7% | — | ||
| Q4 24 | 18.1% | — | ||
| Q3 24 | 4.9% | — | ||
| Q2 24 | 8.8% | — |
资本支出强度KVUERNR
| Q1 26 | — | — | ||
| Q4 25 | 2.9% | — | ||
| Q3 25 | 2.6% | — | ||
| Q2 25 | 2.3% | — | ||
| Q1 25 | 4.8% | — | ||
| Q4 24 | 3.6% | — | ||
| Q3 24 | 1.5% | — | ||
| Q2 24 | 2.3% | — |
现金转化率KVUERNR
| Q1 26 | — | — | ||
| Q4 25 | 2.59× | 0.64× | ||
| Q3 25 | 0.74× | 1.73× | ||
| Q2 25 | 1.48× | 1.76× | ||
| Q1 25 | 1.33× | 0.93× | ||
| Q4 24 | 2.71× | — | ||
| Q3 24 | 0.65× | 1.26× | ||
| Q2 24 | 7.59× | 2.41× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KVUE
| Self Care | $1.6B | 42% |
| Essential Health | $1.1B | 30% |
| Skin Health And Beauty | $1.0B | 28% |
RNR
暂无分部数据
